Covid BioSpec
Research payments
$1,438,426
Through program year 2022, $1,438,426 in research payments was reported against Covid BioSpec, across 34 payments.
- Paid by (largest first)
- Becton, Dickinson and Company; Davol Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2022 | Research | $263,479 | 8 |
| 2021 | Research | $1,174,946 | 26 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Christopher Oldfield Savannah, GA Named on 8 payments
- Luis Castillo Palm Springs, FL Named on 5 payments
- Bernard Garcia Fort Lauderdale, FL Named on 4 payments
- Candice McNeil Winston Salem, NC Named on 3 payments
- Clair Kaplan New Haven, CT Named on 3 payments
- Lashonda Crane Houston, TX Named on 2 payments
- Stephanie Taylor New Orleans, LA Named on 2 payments
- Jeffrey Michelson New Bern, NC Named on 2 payments
- Marc Mickiewicz Gallatin, TN Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.